X BODY Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 16
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $155M
Latest Deal Amount

X BODY General Information

Description

Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functional binding molecules enabling the discovery of human antibodies against therapeutic target.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

X BODY Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2015 $155M 00.00 00000 Completed Generating Revenue
4. Early Stage VC 08-Apr-2015 00.000 00.00 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Jan-2012 00.000 00.000 00.000 Completed Startup
2. Grant 01-Nov-2010 $500K $1M Completed Startup
1. Early Stage VC (Series A) 29-Dec-2008 $1M $1M 000 Completed Startup
To view X BODY’s complete valuation and funding history, request access »

X BODY Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000 00.000000 000 00000.00 00000.00 00 00000.00 00.000
To view X BODY’s complete cap table history, request access »

X BODY Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functiona
Biotechnology
Waltham, MA
16 As of 2015
00.00
0000 0000-00-00
000000&0 00.00

00000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000000000000
Milpitas, CA
00 As of 0000
0000 0000-00-00
000000&0

00000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
000000000 00000 (0000000000)
Cambridge, United Kingdom
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X BODY Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioVision Formerly VC-backed Milpitas, CA 00 000000&0
000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 0 00000
You’re viewing 5 of 39 competitors. Get the full list »

X BODY Patents

X BODY Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021200347-A1 Bi-specific antigen-binding polypeptides Pending 21-Mar-2014 00000000000
CA-2943242-A1 Bi-specific antigen-binding polypeptides Pending 21-Mar-2014 000000000
AU-2015231155-B2 Bi-specific antigen-binding polypeptides Active 21-Mar-2014 00000000000
AU-2015231155-A1 Bi-specific antigen-binding polypeptides Granted 21-Mar-2014 000000000
US-20150299335-A1 Bi-specific antigen-binding polypeptides Granted 21-Mar-2014 C07K16/32
To view X BODY’s complete patent history, request access »

X BODY Executive Team (3)

Name Title Board Seat Contact Info
Gordon Binder Co-Founder & Board Member
Brant Binder President, Co-Founder & Director
You’re viewing 2 of 3 executive team members. Get the full list »

X BODY Board Members (3)

Name Representing Role Since
Brant Binder Self President, Co-Founder & Director 000 0000
Gordon Binder X BODY Co-Founder & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

X BODY Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X BODY Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
United States Department of the Treasury Government 000 0000 000000 0
To view X BODY’s complete investors history, request access »